INS and Hepatic steatosis: The mechanism suggested for the hepatic steatosis related to insulin resistance is that lipid intermediates, especially DAG, can activate PKC, which binds to IR and reduces its activity, consequently reducing IRS phosphorylation and PI3-K/Akt signaling [9], which leads to reduced insulin-stimulated hepatic glycogen synthesis and increased endogenous glucose production [12].